Free Trial

Illumina (ILMN) Competitors

Illumina logo
$97.93 +0.97 (+1.00%)
Closing price 07/17/2025 04:00 PM Eastern
Extended Trading
$98.13 +0.20 (+0.20%)
As of 07/17/2025 07:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ILMN vs. A, MTD, WAT, TECH, CRL, BIO, BRKR, PACB, HBIO, and TMO

Should you be buying Illumina stock or one of its competitors? The main competitors of Illumina include Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), Bio-Techne (TECH), Charles River Laboratories International (CRL), Bio-Rad Laboratories (BIO), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), and Thermo Fisher Scientific (TMO). These companies are all part of the "life sciences tools & services" industry.

Illumina vs. Its Competitors

Illumina (NASDAQ:ILMN) and Agilent Technologies (NYSE:A) are both large-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, risk, institutional ownership, valuation, profitability, dividends, earnings and analyst recommendations.

Agilent Technologies has higher revenue and earnings than Illumina. Illumina is trading at a lower price-to-earnings ratio than Agilent Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Illumina$4.37B3.55-$1.22B-$6.07-16.13
Agilent Technologies$6.51B5.08$1.29B$4.0528.75

In the previous week, Illumina had 6 more articles in the media than Agilent Technologies. MarketBeat recorded 29 mentions for Illumina and 23 mentions for Agilent Technologies. Agilent Technologies' average media sentiment score of 0.99 beat Illumina's score of 0.59 indicating that Agilent Technologies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Illumina
13 Very Positive mention(s)
3 Positive mention(s)
7 Neutral mention(s)
3 Negative mention(s)
2 Very Negative mention(s)
Positive
Agilent Technologies
16 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Illumina has a beta of 1.36, meaning that its stock price is 36% more volatile than the S&P 500. Comparatively, Agilent Technologies has a beta of 1.23, meaning that its stock price is 23% more volatile than the S&P 500.

89.4% of Illumina shares are owned by institutional investors. 2.6% of Illumina shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Agilent Technologies has a net margin of 17.59% compared to Illumina's net margin of -22.25%. Agilent Technologies' return on equity of 25.92% beat Illumina's return on equity.

Company Net Margins Return on Equity Return on Assets
Illumina-22.25% 25.54% 8.62%
Agilent Technologies 17.59%25.92%13.24%

Illumina currently has a consensus target price of $125.11, indicating a potential upside of 27.75%. Agilent Technologies has a consensus target price of $139.77, indicating a potential upside of 20.06%. Given Illumina's higher probable upside, equities analysts clearly believe Illumina is more favorable than Agilent Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Illumina
2 Sell rating(s)
9 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.40
Agilent Technologies
0 Sell rating(s)
6 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.54

Summary

Agilent Technologies beats Illumina on 10 of the 17 factors compared between the two stocks.

Get Illumina News Delivered to You Automatically

Sign up to receive the latest news and ratings for ILMN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ILMN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ILMN vs. The Competition

MetricIlluminaMED IndustryMedical SectorNASDAQ Exchange
Market Cap$15.35B$2.94B$5.57B$9.34B
Dividend YieldN/A2.45%3.80%4.06%
P/E Ratio-16.1320.2928.1019.86
Price / Sales3.55302.32441.4199.92
Price / Cash20.6743.1635.8457.94
Price / Book6.557.838.265.67
Net Income-$1.22B-$55.11M$3.24B$257.80M
7 Day Performance-1.33%3.21%1.48%1.87%
1 Month Performance8.50%12.86%8.07%10.92%
1 Year Performance-15.42%5.06%30.29%18.51%

Illumina Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ILMN
Illumina
4.8555 of 5 stars
$97.93
+1.0%
$125.11
+27.7%
-18.3%$15.35B$4.37B-16.139,030
A
Agilent Technologies
4.7251 of 5 stars
$120.10
-2.6%
$139.77
+16.4%
-12.8%$34.12B$6.51B29.6517,900
MTD
Mettler-Toledo International
4.1541 of 5 stars
$1,195.06
-2.4%
$1,280.90
+7.2%
-12.5%$24.84B$3.83B29.8017,300Positive News
WAT
Waters
4.8105 of 5 stars
$303.93
-13.9%
$388.94
+28.0%
-5.4%$18.09B$2.98B27.587,600Trending News
Analyst Downgrade
Gap Down
High Trading Volume
TECH
Bio-Techne
4.8772 of 5 stars
$52.62
-2.8%
$70.00
+33.0%
-31.9%$8.25B$1.16B64.173,100Positive News
CRL
Charles River Laboratories International
4.7267 of 5 stars
$158.09
-0.8%
$174.54
+10.4%
-29.7%$7.77B$4.05B-243.2120,100
BIO
Bio-Rad Laboratories
4.6436 of 5 stars
$250.92
-2.4%
$324.25
+29.2%
-21.6%$6.83B$2.54B-3.297,700
BRKR
Bruker
4.9775 of 5 stars
$43.21
-1.3%
$52.89
+22.4%
-34.2%$6.55B$3.37B83.1011,396
PACB
Pacific Biosciences of California
1.8855 of 5 stars
$1.46
-0.7%
$2.06
+41.2%
-32.2%$438.12M$154.01M-0.52730Positive News
HBIO
Harvard Bioscience
4.2616 of 5 stars
$0.43
-3.2%
$3.00
+596.7%
-86.9%$19.04M$91.40M-0.33490Trending News
TMO
Thermo Fisher Scientific
4.9925 of 5 stars
$425.44
-2.2%
$600.30
+41.1%
-23.4%$160.60B$42.90B24.95125,000Positive News
Upcoming Earnings

Related Companies and Tools


This page (NASDAQ:ILMN) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners